RPG Life Sciences

Highly Engaged Employees

RPG Life Sciences, founded in 1968 and trading under the ticker NSE: RPGLIFE, is a prominent player in the pharmaceutical and healthcare industries. The company specializes in high-value synthetic Active Pharmaceutical Ingredients (APIs) across various therapeutic categories, including immunosuppressants, anti-psychotics/anti-depressants, anti-thrombotic, anti-anginal, anti-helmentic, anti-convulsant, anti-spasmodic, and anti-cancer agents. Its integrated pharmaceutical operations encompass both API manufacturing and formulation development, supported by a strong emphasis on research and development to consistently launch new products.

With a global footprint spanning Europe, Latin America, and Asia, RPG Life Sciences is actively expanding its presence in the US markets. The company operates with an employee range of 1,000-5,000 individuals and maintains 4 locations. Its modern manufacturing facilities are approved by stringent regulatory bodies such as TGA and numerous international pharmaceutical companies, underscoring its commitment to quality and compliance. Potential partners and stakeholders can learn more about the operational backbone by exploring Meet RPG Life Sciences's team.

The API business is driven by a robust product pipeline, fueled by significant investment in R&D, enabling the consistent introduction of novel APIs. RPG Life Sciences's growing product portfolio features US & EU Drug Master Files (DMFs) in eCTD formats, demonstrating its capability to meet global regulatory standards. The company's strategic focus on R&D and market expansion positions it for sustained growth within the competitive pharmaceutical landscape.